GlassScriptPhysician profile
Steven Cochran Klein
NPI 1366406340
$4,893.97
in general payments reported to CMS, 2019-2025
37 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,419 · 2020: $257 · 2021: $268 · 2022: $1,120 · 2023: $949 · 2024: $560 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,809.91 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $554.19 | 2019-2023 | Xarelto |
| Irhythm Technologies, INC. | $458.00 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Medtronic, INC. | $372.56 | 2022-2025 | Linq II |
| Abbott Laboratories | $368.89 | 2019-2025 | Jot Dx, Aveir, Gallant |
| E.R. Squibb & Sons, L.L.C. | $343.90 | 2019-2022 | |
| Amgen INC. | $336.87 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $259.45 | 2019-2024 | |
| Medtronic Vascular, INC. | $214.80 | 2019-2020 | |
| Pfizer INC. | $207.19 | 2019-2025 | |
| Boston Scientific Corporation | $198.99 | 2019-2025 | Exalt Model D |
| Novartis Pharmaceuticals Corporation | $178.53 | 2019-2024 | |
| Biotronik INC. | $151.12 | 2020-2023 | Acticor 7 Vr-T Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.99 | 2019-2025 | Lifevest |
| Cvrx, INC. | $144.55 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.20 | 2019-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $116.70 | 2024 | Optimizer |
| Atricure, INC. | $97.37 | 2023 | |
| Lundbeck LLC | $77.32 | 2019 | |
| Merck Sharp & Dohme LLC | $77.17 | 2022-2024 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $64.37 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $59.00 | 2019-2023 | Farxiga |
| Amarin Pharma, INC. | $31.17 | 2020 | |
| Philips North America LLC | $30.06 | 2025 | Extended Holter |
| Abiomed | $28.85 | 2024 | Impella |
| Lexicon Pharmaceuticals, INC. | $26.42 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $23.74 | 2025 | |
| Portola Pharmaceuticals, LLC | $23.35 | 2019 | |
| Esperion Therapeutics, INC. | $18.56 | 2025 | Nexletol |
| Novo Nordisk INC | $18.27 | 2024 | Wegovy |
| Chiesi USA, INC. | $17.00 | 2021 | |
| Daiichi Sankyo INC. | $16.56 | 2023 | Injectafer |
| Orphalan INC | $16.31 | 2025 | Cuvrior |
| Celltrion USA INC. | $15.69 | 2025 | Vegzelma |
| Arbor Pharmaceuticals, INC. | $15.23 | 2019 | |
| Heartflow, INC. | $14.63 | 2024 | |
| Ardelyx, INC. | $13.14 | 2022 | |
| Cook Medical LLC | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.